🔎 Trials Near Me

Utama › Sarkoma Ewing › Massachusetts

Kajian klinikal Sarkoma Ewing di Massachusetts

6 kajian untuk Sarkoma Ewing sedang mencari peserta di lokasi di Massachusetts.

Bandar di Massachusetts

Teks kajian rasmi (Bahasa Inggeris)

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  • Dana Farber Cancer Institute, Boston
Mengambil pesertaFasa 1
Umur 2 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07297979

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Dana-Farber Cancer Institute ( Site 1013), Boston
Mengambil pesertaFasa 1/2
6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

Lurbinectedin in FET-Fused Tumors

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
Umur 10 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05918640

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • Mass General Brigham Cancer Institute, Boston
  • Dana Farber Cancer Institute, Boston
Mengambil pesertaFasa 1
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT07197554

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Mengambil pesertaFasa 1/2
Umur 12 hingga 49 · Semua jantina · Dikemas kini 19 Feb 2026 · NCT06709495

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.